ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $176,000 | -91.2% | 16,000 | -88.2% | 0.00% | -100.0% |
| Q4 2022 | $2,006,880 | +47.5% | 135,600 | +90.4% | 0.01% | +50.0% |
| Q3 2022 | $1,361,000 | +105.6% | 71,200 | +157.0% | 0.00% | +100.0% |
| Q3 2021 | $662,000 | -60.8% | 27,700 | -55.3% | 0.00% | -50.0% |
| Q2 2021 | $1,689,000 | -24.8% | 61,900 | -20.2% | 0.00% | -33.3% |
| Q1 2021 | $2,245,000 | +172.5% | 77,600 | +164.8% | 0.01% | +200.0% |
| Q4 2020 | $824,000 | – | 29,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $95,526,552 | 6.92% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $33,000 | 4.12% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $6,259,451 | 2.58% |
| Opaleye Management Inc. | 502,000 | $5,522,000 | 1.65% |
| 1492 Capital Management LLC | 223,516 | $2,458,676 | 1.52% |
| MIRABELLA FINANCIAL SERVICES LLP | 45,299 | $9,849,004 | 1.49% |
| Saturn V Capital Management LP | 178,217 | $1,960,387 | 1.46% |
| AlphaCentric Advisors LLC | 190,000 | $2,090,000 | 1.44% |
| Rubric Capital Management LP | 3,500,000 | $38,500,000 | 1.00% |
| MPM BioImpact LLC | 254,137 | $2,795,507 | 0.73% |